Literature DB >> 26600216

Natural History of Hepatitis C.

Shilpa Lingala1, Marc G Ghany2.   

Abstract

Hepatitis C infection is a common cause of cirrhosis and indication for liver transplantation in the United States. The incidence of chronic hepatitis C has been declining, but rates of cirrhosis and hepatocellular carcinoma are projected to increase. The outcome of chronic hepatitis C is variable. It is estimated that 20% to 25% will develop cirrhosis over a 25-year to 30-year period. The rate of disease progression is influenced by many host, viral, and environmental factors. Few can be modified. Published by Elsevier Inc.

Entities:  

Keywords:  Chronic hepatitis C; Cirrhosis; Decompensated liver disease; Fibrosis; Hepatitis C virus; Natural history

Mesh：

Year:  2015        PMID： 26600216      PMCID： PMC5939344          DOI： 10.1016/j.gtc.2015.07.003

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  128 in total

1.  Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; A Costantino; L A Kondili; F Menniti-Ippolito; B Caroleo; C Costa; G Griffo; L Loiacono; V Pisani; A Focà; M Piazza
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

Authors:  Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; H Kumada
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

3.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

4.  Determinants of the quantity of hepatitis C virus RNA.

Authors:  D L Thomas; J Astemborski; D Vlahov; S A Strathdee; S C Ray; K E Nelson; N Galai; K R Nolt; O Laeyendecker; J A Todd
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

5.  Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.

Authors:  P Mathurin; J Moussalli; J F Cadranel; V Thibault; F Charlotte; P Dumouchel; A Cazier; J M Huraux; B Devergie; M Vidaud; P Opolon; T Poynard
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

6.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

7.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

8.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

9.  Management of the extrahepatic symptoms of chronic hepatitis C: feasibility of a randomized controlled trial of exercise.

Authors:  Olivia McKenna; Caitriona Cunningham; Conor Gissane; Catherine Blake
Journal:  Am J Phys Med Rehabil       Date:  2013-06       Impact factor: 2.159

10.  Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Authors:  L Martin-Carbonero; V de Ledinghen; A Moreno; I Maida; J Foucher; P Barreiro; M Romero; G Satta; J Garcia-Samaniego; J Gonzalez-Lahoz; V Soriano
Journal:  J Viral Hepat       Date:  2009-04-28       Impact factor: 3.728
View more
  52 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 2.  Hepatitis C virus: Promising discoveries and new treatments.

Authors:  Juliana Cristina Santiago Bastos; Marina Aiello Padilla; Leonardo Cardia Caserta; Noelle Miotto; Aline Gonzalez Vigani; Clarice Weis Arns
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

3.  Retreatment of Hepatitis C Infection With Direct-Acting Antivirals.

Authors:  Marisel Segarra-Newnham; Nathalie See; Gail Fox-Seaman
Journal:  Fed Pract       Date:  2020-07

4.  Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients.

Authors:  Anya Mezina; Arunkumar Krishnan; Tinsay A Woreta; Kevin B Rubenstein; Eric Watson; Po-Hung Chen; Carla Rodriguez-Watson
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 5.  Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 7.290

6.  Modulation of Immune Cell Subsets by Hepatitis C Virus and Antiviral Therapy in Early Virological Response HCV Genotype 4-Infected Patients with Compensated Liver Disease.

Authors:  Sahar Essa; Raja'a Al-Attiyah; Iqbal Siddique; Widad Al-Nakib
Journal:  Med Princ Pract       Date:  2020-09-23       Impact factor: 1.927

7.  Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus.

Authors:  Sammy Saab; Timothy Ahn; Terina McDaniel; Beshoy Yanny; Myron J Tong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08

8.  Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort.

Authors:  M Elaine Eyster; Lan Kong; Menghan Li; Ian R Schreibman
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

9.  Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers.

Authors:  Ameer Abutaleb; Jose Antonio Almario; Saleh Alghsoon; Ji Ae Yoon; Kate Gheysens; Shyam Kottilil; Eleanor Wilson
Journal:  J Clin Exp Hepatol       Date:  2020-08-09

10.  Establishing an Epidemiologic Profile of Hepatitis C Virus Infection at the Los Angeles County Jail.

Authors:  Nazia Qureshi; Martha Tadesse; NgocDung Tran; Sean Henderson
Journal:  Public Health Rep       Date:  2021-02-18       Impact factor: 2.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.